Atypic central serous chorioretinopathy in patient treated by systemic corticosteroid therapy

Authors

  • Nibrass Chaker
  • Ahmed ChebiL
  • Fedra Kort
  • Bouraoui Rim
  • Leila El MatrI

Downloads

Download data is not yet available.

References

Sato H, Ito S, Nagai S, Murasawa A, Wada Y, Murakami S, et al. Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid. Mod Rheumatol 2013 ;23:172-4

Steichen O, Chauveheid MP, Lidove O, Doan S, Papo T Iatrogenic central serous chorioretinopathy during glucocorticoid therapy for temporal arteritis La revue de medicine interne 2006; 27: 702-5.

Otsuka S, Ohba N, Nakao K. A long-term follow-up study of severe variant of - -central serous chorioretinopathy. Retina 2002; 22:25-32.

Sharma T, Shah N, Rao M, Gopal L. Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. Ophthalmology 2004; 111:1708-14.

Downloads

Published

2015-02-16

Issue

Vol. 92 No. 8 (2014): Issue Aug 2014

Section

brief case reports